Relmada Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.7M | 574k | 3.00 |
| 2023-06-30 | $1.5M | 605k | 2.46 |
| 2023-03-31 | $4.2M | 1.8M | 2.26 |
| 2022-12-31 | $6.5M | 1.9M | 3.49 |
| 2022-06-30 | $41M | 2.2M | 18.99 |
| 2021-06-30 | $47M | 1.5M | 32.02 |
| 2021-03-31 | $53M | 1.5M | 35.27 |
| 2020-12-31 | $48M | 1.5M | 32.07 |
| 2020-09-30 | $46M | 1.2M | 37.59 |
| 2020-03-31 | $16M | 478k | 34.11 |
| 2019-12-31 | $5.6M | 143k | 39.02 |